anti-KLK2 CAR T cells JNJ-75229414
Term · Oncology and biomedicine · MLC-T-ONC-010838
A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting human kallikrein-2 (hK2; KLK2) expressed on tumor cells, with potential immunostimulating and antineoplastic activities. Upon administration, anti-KLK2 CAR T cells JNJ-75229414 target and bind to KLK2-expressing tumor cells, thereby inducing selective toxicity in KLK2-expressing tumor cells. KLK2 is overexpressed in certain tumors, including prostate adenocarcinoma.
| Identifier | MLC-T-ONC-010838 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-kallikrein-2 CAR T cells JNJ-75229414; KLK2 CAR-T cells JNJ-75229414 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010838",
"term": "anti-KLK2 CAR T cells JNJ-75229414",
"field": "Oncology and biomedicine",
"definition": "A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting human kallikrein-2 (hK2; KLK2) expressed on tumor cells, with potential immunostimulating and antineoplastic activities. Upon administration, anti-KLK2 CAR T cells JNJ-75229414 target and bind to KLK2-expressing tumor cells, thereby inducing selective toxicity in KLK2-expressing tumor cells. KLK2 is overexpressed in certain tumors, including prostate adenocarcinoma.",
"synonyms": [
"anti-kallikrein-2 CAR T cells JNJ-75229414",
"KLK2 CAR-T cells JNJ-75229414"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-klk2-car-t-cells-jnj-75229414/"
}
Record 1,955 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.